Hyperlipidemic Rabbit Models for Anti-Atherosclerotic Drug Development
Hyperlipidemia or dyslipidemia is a major risk factor for atherosclerotic diseases. Experimental animals play an important role in elucidating the molecular mechanisms of the pathophysiology of hyperlipidemia as well as in drug development. Rabbits are one of the most suitable models to study human...
Main Authors: | Manabu Niimi, Yajie Chen, Haizhao Yan, Yao Wang, Tomonari Koike, Jianglin Fan |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-12-01
|
Series: | Applied Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-3417/10/23/8681 |
Similar Items
-
Lack of Atherosclerotic Lesion Progression on Severe Hyperlipidemic Rabbits
by: DIMAS ANDRIANTO, et al.
Published: (2009-06-01) -
Pathological Investigations of Intracranial Atherosclerosis Using Multiple Hypercholesterolemic Rabbit Models
by: Xiangming Tang, et al.
Published: (2022-05-01) -
Defects of the LDL receptor in WHHL transgenic rabbits lead to a marked accumulation of plasma lipoprotein[a]
by: Jianglin Fan, et al.
Published: (2000-06-01) -
Assessment of glibenclamide pharmacokinetics in poloxamer 407-induced hyperlipidemic rats
by: Yousef A. Bin Jardan, et al.
Published: (2021-07-01) -
Effectiveness of Shelled Almonds in Decreasing Blood Lipid and Lipoprotein Levels of Hyperlipidemic Patients
by: H Mozaffari, et al.
Published: (2008-10-01)